Chronic Kidney Disease News

Adults with chronic kidney disease managed with hemodiafiltration reported less drop in health-related of quality of life, particularly in cognitive decline, compared with those using hemodialysis, according to data from the CONVINCE trial.

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.

Women on in-center hemodialysis generally may experience more headaches and other symptoms than men, according to results of a published cluster study.

Adults with early kidney disease who live in unemployed or lower-skilled households may have higher mortality rates compared with those in professional households, according to published data.

GLP-1 receptor agonist use on top of SGLT2 inhibition in patients with HF with preserved ejection fraction, type 2 diabetes and obesity was associated with reduced risk for adverse events vs. SGLT2 inhibition alone, researchers reported.

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.

More than half of patients with diabetes undergoing kidney biopsy had additional findings other than diabetic kidney disease, according to published data from the Cleveland Clinic Florida.

Rate and progression of chronic kidney disease may increase with age, according to a published study, but estimates could vary based on the filtration marker used.

Belzutifan significantly improved PFS and objective response compared with everolimus for patients with advanced renal cell carcinoma, according to results of a randomized phase 3 trial.

Use of the 2021 Chronic Kidney Disease-Epidemiology Collaboration creatinine equation led to identifying a lower rate of CKD among Korean and U.S. Asian populations, a published study shows.